Stryker Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 17.11B | 18.45B | 20.50B | 22.59B | 25.12B | 11.2% | |
| Cost of Revenue | (6.40B) | (7.41B) | (8.00B) | (8.62B) | (9.05B) | 5.1% | |
Gross Profit | 10.71B | 11.04B | 12.49B | 13.98B | 16.07B | 14.9% | |
| Operating Expenses | |||||||
| Research & Development | (1.13B) | (1.23B) | (1.29B) | (1.41B) | (1.58B) | 11.9% | |
| Selling, General & Administrative | (5.81B) | (6.08B) | (6.92B) | (7.50B) | (8.65B) | 15.3% | |
| Depreciation & Amortization | (990.00M) | (998.00M) | (1.03B) | (1.05B) | (1.19B) | 13.6% | |
Operating Income (EBIT) | 3.76B | 3.73B | 4.28B | 5.06B | 4.89B | -3.4% | |
| Non-Operating Items | |||||||
| Interest Income | 68.00M | 94.00M | 75.00M | 139.00M | 121.00M | -12.9% | |
| Interest Expense | (337.00M) | (337.00M) | (356.00M) | (396.00M) | (607.00M) | 53.3% | |
| Other Income/Expenses (Net) | -1.48B | -1.05B | -608.00M | -1.57B | -375.00M | -76.1% | |
Income Before Tax | 2.28B | 2.68B | 3.67B | 3.49B | 4.51B | 29.3% | |
| Income Tax Expense | (287.00M) | (325.00M) | (508.00M) | (499.00M) | (1.27B) | 154.1% | |
Net Income | 1.99B | 2.36B | 3.17B | 2.99B | 3.25B | 8.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $5 | $6 | $8 | $8 | $8 | 8.0% | |
| Weighted Avg Shares Outstanding | 377.00M | 378.20M | 379.60M | 381.00M | 382.20M | 0.3% | |
| Weighted Avg Shares Outstanding (Diluted) | 382.30M | 382.20M | 383.70M | 385.60M | 382.20M | -0.9% | |
EBITDA | 3.61B | 4.02B | 5.06B | 4.94B | 6.31B | 27.9% |
Explore SYK
SYK in the Healthcare
Large Cap